Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, featuring promising breakthroughs throughout several healthcare and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, more reputable option for therapeutic use, significa